IMMULITE/IMMULITE 1000 AFP AND IMMULITE 2000/IMMULITE 2500 AFP

Kit, Test, Alpha-fetoprotein For Neural Tube Defects

FDA Premarket Approval P010007

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for immulite afp for use with the immulite analyzer and immulite 2000 afp for use with the immulite 2000 analyzer. These devices are indicated for in vitro diagnostic use for the quantitative measurement of alpha-fetoprotein (afp) in either of two contexts: a) serial measurements in human serum to aid in the management of patients with nonseminomatous testicular cancer: or b) measurement in maternal serum and amniotic fluid during gestational weeks 15 through 20 - used in conjunction with ultrasonography or amniography - to aid in detection of fetal open neural tube defects.

DeviceIMMULITE/IMMULITE 1000 AFP AND IMMULITE 2000/IMMULITE 2500 AFP
Classification NameKit, Test, Alpha-fetoprotein For Neural Tube Defects
Generic NameKit, Test, Alpha-fetoprotein For Neural Tube Defects
ApplicantSIEMENS HEALTHCARE DIAGNOSTICS INC.
Date Received2001-02-13
Decision Date2001-11-09
Notice Date2001-12-05
PMAP010007
SupplementS
Product CodeLOK
Docket Number01M-0537
Advisory CommitteeImmunology
Expedited ReviewNo
Combination Product No
Applicant Address SIEMENS HEALTHCARE DIAGNOSTICS INC. 511 Benedict Ave. tarrytown, NY 10591
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P010007Original Filing
S017 2022-09-15 30-day Notice
S016
S015 2022-02-28 30-day Notice
S014 2021-04-14 30-day Notice
S013 2020-08-12 30-day Notice
S012 2020-07-23 30-day Notice
S011 2019-11-25 30-day Notice
S010 2018-09-28 Real-time Process
S009 2012-05-30 135 Review Track For 30-day Notice
S008 2011-12-19 135 Review Track For 30-day Notice
S007 2011-08-16 30-day Notice
S006 2011-08-08 30-day Notice
S005 2011-02-18 Real-time Process
S004 2009-11-02 Normal 180 Day Track No User Fee
S003
S002 2003-12-12 Real-time Process
S001 2003-01-21 Real-time Process

NIH GUDID Devices

Device IDPMASupp
00630414963594 P010007 001
00630414961040 P010007 001
00630414961033 P010007 001
00630414953519 P010007 001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.